News search

    E.g., 23/08/2025
    E.g., 23/08/2025
    About the CNIC
    3 Apr 2019
    Adiponectin, the hormone that protects women against liver cancer
    • Adiponectin, secreted by adipose tissue, protects against the development of the main form of liver cancer
    • Women produce the hormone in larger quantities than men, and adiponectin release also declines in people with obesity
    • The results open the route to combating a cancer for which there is currently no treatment and that is the fourth cause of death in the world.
    Borja Ibáñez, Carlos Galán, Rodrigo Fernández, Eduardo Oliver, Gonzalo Pizarro, Manuel Lobo, Jean Paul Vilchez Tschischke, Antonio de Molina-Iracheta, Rocío Villena y Javier Sánchez-González
    Research
    19 Feb 2019
    JACC: Identified a very early marker of cardiac damage triggered by cancer treatment

    The results have implications for patient prognosis, since detection of this marker can prompt intervention to prevent irreversible damage
    La Dra. Guadalupe Sabio en su laboratorio.
    About the CNIC
    25 Oct 2017
    Dr. Guadalupe Sabio joins the EMBO’s network of young researchers

    Dr. Sabio leads a research group at the Carlos III National Cardiovascular Research Center (CNIC) whose main line of research are diseases related to obesity, like cardiovascular diseases, diabetes and liver cancer.


    The CNIC research team. From left to right: Andrés Hidalgo, David Sancho, Sarai Martínez-Cano, Salvador Iborra, Elena Priego, Michel Enamorado, and Juan Antonio Quintana.
    Research
    17 Jul 2017
    `'Nature Comunications': Scientists Find the Key to Improved Cancer Immunotherapy

    The study, published in Nature Communications, demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
    Ángel Álvarez Prado, Prof. Jesús Vázquez, Juan Antonio López del Olmo, Dra. Almudena Ramiro y Dra. Virginia G. de Yébenes
    Research
    22 Feb 2017
    'Blood': New Treatment Target Identified for Aggressive Lymphomas

    Every year 400000 people are diagnosed with lymphoma, and 200000 people die from the consequences of this blood cancer
    Publications
    8 Sep 2015
    EMBO Molecular Medicine: Descubren un nuevo mecanismo inmune contra el cáncer

    Investigadores del Centro Nacional de Investigaciones Cardiovasculares (CNIC) han descubierto por primera vez un mecanismo de protección contra el desarrollo de cáncer asociado a procesos inflamatorios
    Publications
    3 Jun 2014
    Logran reproducir por primera vez en células humanas las translocaciones cromosómicas propias de algunos tipos de cáncer
    Research
    1 Jun 2012
    Miguel Ángel del Pozo recibe el Premio Ciencias de la Salud

    El trabajo arroja luz sobre un tema controvertido, el papel de Cav1 en cáncer, considerada como supresor o promotor tumoral por distintos grupos